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To the Editor: Evenepoel P et al.1 compared the clearance of
b2 microglobulin (b2M) by hemodialysis and peritoneal
dialysis (PD).
Previously, it was postulated that clearance of middle
molecule b2M was greater with PD, as compared to
hemodialysis. However, with introduction of high perfor-
mance dialysis membrane, hemodialysis now appears to be
superior in this aspect. Hereby, we examined the ways in
which decreasing residual renal function had an effect on
serum b2M levels in patients on PD. Associations of b2M
clearance by PD and residual renal function, and serum b2M
levels with duration of dialysis were investigated in 20
subjects on continuous ambulatory PD. The results showed
that serum b2M levels increased with duration of dialysis. As
for b2M clearance by residual renal function per se, it was
significantly lower in subjects with long duration of dialysis
even though no difference was observed in the daily b2M
clearance by PD (Figure 1).
Dialysis adequacy had traditionally been determined by Kt/
V, urinary nitrogen.2 However, in HEMO study, it became
apparent that serum b2M levels, not Kt/V were the strong
predictors of mortality.3 There have been reported that
mortality is lower for PD, as compared to hemodialysis up to
48 months from commencement of PD, provided that there is
residual renal function.4 Although our study only focused on
the changes in serum b2M levels, attempts should be made by
future studies to search for dialysis methods that provide
adequate b2M clearance with a potential decrease in mortality.
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We thank Yoshida et al.1 for their interest in our study
examining the clearance of b2-microglobulin (B2M) and
p-cresol in dialysis patients. The authors report data from
a cross-sectional study on serum levels and clearances of
B2M in 20 patients treated with peritoneal dialysis. Both
parameters showed significant but opposite correlations
with duration of dialysis. This observation is in line with
the results of a recent prospective study in incident
peritoneal dialysis patients.2 In the latter study, serum
levels of B2M were also shown to increase with time on
dialysis. A declining renal clearance, not compensated by
an increased peritoneal clearance emerged as the most
plausible explanation. It is increasingly recognized that
residual renal function is of utmost importance for the
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Figure 1 | Serum b2M levels was increased with duration of
dialysis, urine b2M clearance was decreased and PD b2M
clearance was constant.
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